KIA
EW icon

KCM Investment Advisors’s Edwards Lifesciences EW Stock Holding History

KCM Investment Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,496
Closed -$424K – 374
2023
Q2 		$424K Buy
+4,496
New +$391K 0.02% 275

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

KCM Investment Advisors's EW Position: Q2 2026 in Review

KCM Investment Advisors opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,479 shares worth $224K. The stake represents 0.01% of the portfolio and ranks #386 among its holdings. This is a return to the name: KCM Investment Advisors previously reported a position in EW as recently as Q4 2025.

KCM Investment Advisors first reported a position in EW in Q4 2016 and has held it in 29 quarters since. The position peaked at $680K in Q4 2021. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • KCM Investment Advisors held 2,479 shares of Edwards Lifesciences worth $224K as of Q2 2026.
  • Edwards Lifesciences was a new KCM Investment Advisors position in Q2 2026.
  • Edwards Lifesciences made up 0.01% of KCM Investment Advisors's portfolio in Q2 2026, its #386 holding.
  • KCM Investment Advisors first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 29 quarters since.
  • KCM Investment Advisors's Edwards Lifesciences position peaked at $680K in Q4 2021.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on KCM Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.